Background:Smith-Lemli-Opitz Syndrome (SLOS) is a genetic disorder. It can cause birth defects and developmental delays. There is no cure for SLOS or other inherited diseases related to cholesterol production or storage. The data gained in this study may help researchers find ways to measure how well future treatments work.
Who is this study for: Patients with Smith-Lemli-Opitz Syndrome, Cone-Rod Dystrophy, Hearing Loss
Enrollment Status: Recruiting
Publish Date: January 20, 2022
Intervention Type: Drug
Study Phase: Phase 2
Summary: Patients with biochemically confirmed SLOS are being treated with cholesterol supplementation and antioxidant medication. They are carefully monitored with visits to clinic, laboratory testing including cholesterol and 7-dehydrocholesterol levels, vitamin levels, blood counts and liver and kidney function. On a serial basis, no more often than once a year, the patients undergo a series of tests un...